. Author manuscript; available in PMC: 2017 Jul 1.

Published in final edited form as: Clin Gastroenterol Hepatol. 2016 Feb 22;14(7):973–979. doi: 10.1016/j.cgh.2016.02.017

Table 4.

Results of stratified analysis between statin use and risk of colorectal cancer in inflammatory bowel diseases

	Adjusted Odds ratio	95% Confidence interval
By type of inflammatory bowel disease
Ulcerative colitis	0.57	0.35 – 0.93
Crohn’s disease	0.15	0.06 – 0.35
By gender
Female	0.36	0.18 – 0.75
Male	0.35	0.21 – 0.59
Smoking status
Never smoker	0.20	0.05 – 0.87
Ever smoker	0.44	0.29 – 0.67

P (interaction) > 0.05 for all comparisons